FDA Approved: ARGATROBAN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Argatroban to update the product labeling. The change was submitted by Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia
• Thrombosis

Drugs mentioned

• Argatroban (argatroban)

Snippet

SUPPL AP for ARGATROBAN (ARGATROBAN)